DNMT3A and breast carcinoma: For example, lower change in expression level of DNA methylating enzymes DNMT3A was observed in breast cancer cell lines 3 days after azacytidine treatment, as compared to colon and ovarian cancer cell lines (Supplementary Figure 5).